Quercetin Plus Daidzein, Icariin and Genistein
Quercetin Plus Daidzein, Icariin and Genistein, NPN 80136074: natural health product licensed in Canada. Medicinal ingredients: 4',5,7-Trihydroxyisoflavone, 7-hydroxy-3-(4-hydroxyphényl)-4H-1-benzopyran-4-one.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 4',5,7-Trihydroxyisoflavone Source : Genistein | 1.5 mg | Not calculated |
| 7-hydroxy-3-(4-hydroxyphényl)-4H-1-benzopyran-4-one | 7.5 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropyle Cyclodextrine, Trehalose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | minimum: 18 years | 1 Cuillère à café | 2 Tous les jours |
Uses authorised in Canada
Source of/Provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are pregnant or breastfeeding. Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or any hormone replacement therapy. Ask a health care practitioner/health care provider/health care professional /doctor/physician before use if you are not up-to-date on mammograms and gynaecological evaluations. Ask a health care practitioner /health care provider/ health care professional / doctor /physician before use if you have a liver disorder or a history of hormonal or gynaecological disease.
- Contra-Indications
Do not use if you have or had breast cancer or tumours or a predisposition to breast cancer, as indicated by an abnormal mammogram or biopsy, or a family member with breast cancer. Stop use and ask a health care practitioner / health care provider/health care professional/doctor/physician if new symptoms develop such as breast pain, a recurrence of menstruation, uterine spotting or liver-related symptoms (e.g. abdominal pain, jaundice, dark urine).
Product record
- Licence holder
- LeralabInc
- NPN or DIN-HM
- 80136074
- Status
- Active licence
- Licence date
- 18 November 2024
- Revision date
- Not provided
- Form
- Poudre pour solution
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80136074
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Quercetin Plus Daidzein, Icariin and Genistein (LeralabInc): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80136074-quercetin-plus-daidzein-icariin-and-genistein, updated 18 November 2024.